We are live on ! Find out more
PVAM

Pacific View Asset Management Portfolio holdings

AUM $20.8M
1-Year Est. Return 20.08%
This Fund
S&P 500
This Quarter Est. Return
+5.69%
1 Year Est. Return
+20.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
-$6.42M
Cap. Flow
-$10M
Cap. Flow %
-7.91%
Top 10 Hldgs %
43.52%
Holding
126
New
18
Increased
44
Reduced
31
Closed
31

Top Buys

Rank Stock Value
1
GVA icon
Granite Construction
GVA
+$4.51M
2
ARRY
Array Biopharma Inc
ARRY
+$3.59M
3
AIMT
Aimmune Therapeutics
AIMT
+$2.62M
4
AERI
Aerie Pharmaceuticals
AERI
+$2.47M
5
PNFP icon
Pinnacle Financial Partners Inc
PNFP
+$2.46M

Top Sells

Rank Stock Value
1
MNRO icon
Monro
MNRO
+$2.43M
2
SNDR icon
Schneider National
SNDR
+$1.89M
3
LHCG
LHC Group LLC
LHCG
+$1.47M
4
MXWL
Maxwell Technologies Inc
MXWL
+$1.21M
5
ASXC
Asensus Surgical, Inc.
ASXC
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 21.06%
2 Healthcare 18.93%
3 Financials 12.68%
4 Technology 9.76%
5 Consumer Staples 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GIFI
1
DELISTED
Gulf Island Fabrication
GIFI
$7.21M 5.71%
800,846
+18,496
+2% +$177K
UTI icon
2
Universal Technical Institute
UTI
$2.09B
$6.9M 5.46%
2,190,962
+282,717
+15% +$868K
KIN
3
DELISTED
Kindred Biosciences, Inc.
KIN
$5.8M 4.59%
545,000
+55,000
+11% +$536K
SAGE
4
DELISTED
Sage Therapeutics
SAGE
$5.5M 4.36%
35,174
+13,697
+64% +$2.15M
GVP
5
DELISTED
GSE Systems, Inc.
GVP
$5.4M 4.27%
166,133
+255
+0.2% +$8.24K
AIMT
6
DELISTED
Aimmune Therapeutics
AIMT
$5.23M 4.14%
194,628
+85,644
+79% +$2.62M
PNFP icon
7
Pinnacle Financial Partners Inc
PNFP
$15B
$4.97M 3.93%
81,021
+37,896
+88% +$2.46M
GVA icon
8
Granite Construction
GVA
$5.34B
$4.96M 3.93%
89,110
+79,829
+860% +$4.51M
AERI
9
DELISTED
Aerie Pharmaceuticals
AERI
$4.64M 3.67%
68,666
+44,069
+179% +$2.47M
ISBC
10
DELISTED
Investors Bancorp, Inc.
ISBC
$4.36M 3.45%
341,153
+159,313
+88% +$2.15M
HOMB icon
11
Home BancShares
HOMB
$6.09B
$4.31M 3.41%
191,141
+54,012
+39% +$1.25M
URA icon
12
Global X Uranium ETF
URA
$5.35B
$3.91M 3.1%
304,000
– –
ARRY
13
DELISTED
Array Biopharma Inc
ARRY
$3.78M 3%
+225,511
New +$3.59M
PRAH
14
DELISTED
PRA Health Sciences, Inc.
PRAH
$3.42M 2.71%
36,625
+14,841
+68% +$1.28M
ADSW
15
DELISTED
Advanced Disposal Services Inc
ADSW
$2.5M 1.98%
100,820
+33,966
+51% +$789K
HCSG icon
16
Healthcare Services Group
HCSG
$1.71B
$2.4M 1.9%
55,597
-10,077
-15% -$400K
GDXJ icon
17
VanEck Junior Gold Miners ETF
GDXJ
$6.62B
$1.84M 1.46%
56,300
– –
SYNH
18
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$1.72M 1.36%
36,713
-5,916
-14% -$245K
NAII icon
19
Natural Alternatives International
NAII
$13.5M
$1.64M 1.3%
161,897
-5,626
-3% -$59.3K
SUM
20
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.63M 1.29%
63,021
+28,169
+81% +$785K
ABM icon
21
ABM Industries
ABM
$2.77B
$1.29M 1.02%
+44,209
New +$1.36M
KNX icon
22
Knight Transportation
KNX
$12.3B
$1.29M 1.02%
33,687
+18,151
+117% +$747K
EVOL
23
DELISTED
Evolving Systems, Inc.
EVOL
$1.28M 1.01%
449,539
-28,005
-6% -$98.3K
ABCB icon
24
Ameris Bancorp
ABCB
$6.11B
$1.21M 0.96%
22,727
+11,429
+101% +$625K
IMMU
25
DELISTED
Immunomedics Inc
IMMU
$1.16M 0.92%
49,167
+30,990
+170% +$623K
1
2 3 4 5

Similar funds

CIM
Consilium Investment Management Ft. Lauderdale, Florida $21M AUM 29.5% 1-Year Est. Return
ICP
IBIS Capital Partners London, United Kingdom $19.4M AUM 0.49% 1-Year Est. Return
QI
Quilter Investors London, United Kingdom $22.3M AUM 6.63% 1-Year Est. Return
HWM
Highwater Wealth Management Glendale, Colorado $22.6M AUM 3.46% 1-Year Est. Return
AGU
Alpine Group USVI St. Thomas, U.S. Virgin Islands $23.4M AUM
PCP
Prisma Capital Partners New York $17.5M AUM 42.28% 1-Year Est. Return
MAU
MRA Associates USA Phoenix, Arizona $25.4M AUM 0.38% 1-Year Est. Return
FCG
FrontFour Capital Group Greenwich, Connecticut $26.5M AUM 17.69% 1-Year Est. Return

Pacific View Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Pacific View Asset Management held 126 positions worth $126M, down 4.8% from $133M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Pacific View Asset Management withdrew a net $10M in Q2 2018, closing 31 positions and reducing 31 holdings. Its most notable exit was Monro, an estimated $2.43M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Pacific View Asset Management opened a new position in Array Biopharma Inc worth $3.78M.

  • Pacific View Asset Management's largest Q2 2018 buy was Array Biopharma Inc: 225,511 shares worth $3.78M.
  • Pacific View Asset Management added most to Granite Construction in Q2 2018, an estimated $4.51M increase.
  • Pacific View Asset Management's biggest Q2 2018 reduction was LHC Group LLC, cutting an estimated $1.47M.
  • Pacific View Asset Management fully exited Monro in Q2 2018, selling an estimated $2.43M.
  • Pacific View Asset Management's ten largest holdings make up 44% of its $126M portfolio in Q2 2018.
  • Pacific View Asset Management opened 18 new positions and closed 31 in Q2 2018.
  • Pacific View Asset Management's portfolio value fell 4.8% quarter-over-quarter to $126M.

Based on Pacific View Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.